Camillo Ribi

Publications | Mémoires et thèses

La recherche avancée est accessible via Serval

Les publications peuvent être gérées en accédant à Serval via MyUnil


150 publications

Sous presse | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2006 | 2005 | 2003 | 2002 |
Sous presse
 
Chapter 68. Systemic Lupus Erythematosus
Baglivo E Ribi C. dans Intraocular Inflammation, Zierhut M, et al..
[serval:BIB_D58BC7343FB4]
2024
 
Fake news en médecine et leur impact sur nos patients. L’exemple de l’hydroxychloroquine.
Ribi C., 2024/04/03. Revue medicale suisse, 20 (868) pp. 679-680. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_FD40C04EE551]
 
La connectivite mixte et sa prise en charge [Mixed connective tissue disease and its management]
Curraj E., Belkoniene M., Keutchakeu-Tchatcho C., Ringwald M., Ribi C., 2024/04/03. Revue medicale suisse, 20 (868) pp. 699-704. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_F3EAB7D18540]
 
Sarcoïdose cardiaque : un défi diagnostique et thérapeutique [Cardiac sarcoidosis: a diagnostic and therapeutic challenge]
Ammann S., Dominati A., Meyer P., Pruvot E., Ribi C., Seebach J., 2024/04/03. Revue medicale suisse, 20 (868) pp. 682-687. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_EFA8F7C80D0B]
 
Thérapie cellulaire CAR-T dans le traitement des maladies auto-immunes [CAR-T therapy for autoimmune diseases]
Alcaraz-Serna A., Porret R., Trueb L., Ribi C., Seebach J., Muller Y.D., 2024/04/03. Revue medicale suisse, 20 (868) pp. 688-693. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_FC7F901BBC55]
Therapeutic management of fibrosis in systemic sclerosis patients - an analysis from the Swiss EUSTAR cohort.
Windirsch K., Jordan S., Becker M.O., Bruni C., Dobrota R., Elhai M., Garaiman I.A., Mihai C.M., Iudici M., Hasler P. et al., 2024/02/06. Swiss medical weekly, 154 p. 3630. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_A434393F87C4]
 
Immunologie: ce qui a changé en 2023 [Immunology: what's new in 2023]
Ringwald M., Ribi C., 2024/01/17. Revue medicale suisse, 20 (856-7) pp. 47-50. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_DF897A402A27]
Risk factors for allergy documentation in electronic health record: A retrospective study in a tertiary health center in Switzerland.
Ringwald M., Moi L., Wetzel A., Comte D., Muller Y.D., Ribi C., 2024/01. Allergology international, 73 (1) pp. 143-150. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_931C991F3DB5]
2023
 
Benralizumab for eosinophilic granulomatosis with polyangiitis: a retrospective, multicentre, cohort study.
Bettiol A., Urban M.L., Padoan R., Groh M., Lopalco G., Egan A., Cottin V., Fraticelli P., Crimi C., Del Giacco S. et al., 2023/12. The Lancet. Rheumatology, 5 (12) pp. e707-e715. Peer-reviewed.
[DOI][Pmid][serval:BIB_24C3A2CB1959]
 
Worse cardiovascular and renal outcome in male SLE patients.
Mihailovic J., Ribi C., Chizzolini C., Trendelenburg M., Von Kempis J., Dahdal S., Huynh-Do U., Swiss Systemic Lupus Erythematosus Cohort Study Group (SSCS), 2023/10/30. Scientific reports, 13 (1) p. 18628. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_6E0F97DEE154]
 
Myositis manifesting as respiratory insufficiency with anti-RNA polymerase III antibodies: an unusual presentation of graft-versus-host disease.
Wolff L., Clottu A., Mamez A.C., Ribi C., Grandoni F., 2023/09. Leukemia & lymphoma, 64 (9) pp. 1588-1591. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_3D11BC441C65]
 
Relentless bilateral occlusive vasculitis in a patient with Crohn's disease treated with adalimumab after immunization with mRNA SARS-CoV-2 vaccine: a case report
Bughin Alice, Casanova Alex, Ribi Camillo, Guex-Crosier Yan, 2023/08/25..
[DOI][serval:BIB_DD232EBEFAC7]
 
Insuffisance cardiaque aiguë comme présentation principale d'un syndrome catastrophique des antiphospholipides
Friedrich Bastien P., Burger Raphal, Alberio Lorenzo, Girod Grgoire, Kissling Sbastien, Grandoni Francesco, Graf Guillaume, Ribi Camillo, 2023/08/16. Forum Médical Suisse ‒ Swiss Medical Forum.
[DOI][serval:BIB_ADEB2BF23102]
 
Eosinophilic Granulomatosis with Polyangiitis after mRNA-1273 SARS-CoV-2 Vaccine.
Mencarelli L., Moi L., Dewarrat N., Monti M., Alberio L., Ringwald M., Swierdzewska K., Panagiotis A., Ribi C., 2023/08/07. Vaccines, 11 (8) p. 1335. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_6CE251741A8E]
 
Cutaneous Manifestations, Clinical Characteristics, and Prognosis of Patients With Systemic Sclerosis Sine Scleroderma: Data From the International EUSTAR Database.
Lescoat A., Huang S., Carreira P.E., Siegert E., de Vries-Bouwstra J., Distler JHW, Smith V., Del Galdo F., Anic B., Damjanov N. et al., 2023/08/01. JAMA dermatology, 159 (8) pp. 837-847. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_6D3F9BC1AB36]
A severe case of neuroleukemiosis caused by B cell chronic lymphocytic leukemia, presenting as mononeuritis multiplex.
Vicino A., Cochet S., Pistocchi S., Conrad C., Ribi C., Du Pasquier R., Brouland J.P., Théaudin M., 2023/06. Journal of the peripheral nervous system, 28 (2) pp. 266-268. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_0A5312D01C4F]
 
ITGAM rs1143679 Variant in Systemic Lupus Erythematosus Is Associated with Increased Serum Calcification Propensity.
Halfon M., Zhang L., Ehirchiou D., Pandian V.D., Dahdal S., Huynh-Do U., Pasch A., Ribi C., Busso N., 2023/05/18. Genes, 14 (5) p. 1105. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_B144EDB59ADF]
 
Granulomatose avec polyangéite : quoi de neuf ? [Granulomatosis with polyangiitis: what's new?]
Ringwald M., Chevalley D., Bongard C., Kissling S., Rotman S., Von Garnier C., Ribi C., Comte D., 2023/04/05. Revue medicale suisse, 19 (821) pp. 674-679. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_D369BEFFD011]
 
La concision est l’âme de l’esprit.
Seebach J.D., Ribi C., 2023/04/05. Revue medicale suisse, 19 (821) pp. 655-656. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_43703F2D61EC]
 
Maladie des anticorps anti-membrane basale glomérulaire [Anti-glomerular basement membrane disease]
Stevanin M., Kissling S., Daccord C., Rotman S., Comte D., Ribi C., 2023/04/05. Revue medicale suisse, 19 (821) pp. 680-685. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_89863117120D]
Management of giant-cell arteritis in Switzerland: an online national survey.
Iudici M., Hemmig A.K., Stegert M., Courvoisier D.S., Adler S., Becker M.O., Berger C.T., Dan D., Finckh A., Mahr A. et al., 2023/04/03. Swiss medical weekly, 153 p. 40051. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_2742B450E525]
Graded-dosing immunization in adults at risk for immediate-type reactions to mRNA SARS-CoV-2 vaccines.
Stehlin F., Tommasini F., Monzambani-Banderet V., Girard C., Yerly D., Ribi C., Muller Y.D., 2023/04. Allergology international, 72 (2) pp. 332-334. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_F1AE52F9BF9D]
Case report: First-in-human combined low-dose whole-heart irradiation and high-dose stereotactic arrhythmia radioablation for immunosuppressive refractory cardiac sarcoidosis and ventricular tachycardia.
van der Ree M.H., Herrera Siklody C., Le Bloa M., Pascale P., Porretta A.P., Teres C.C., Solana Munoz J., Luca A., Domenichini G., Ozasahin M. et al., 2023. Frontiers in cardiovascular medicine, 10 p. 1213165. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_FA14CF085E93]
2022
 
Phenotype of limited cutaneous systemic sclerosis patients with positive anti-topoisomerase I antibodies: data from the EUSTAR cohort.
Zanatta E., Huscher D., Ortolan A., Avouac J., Airò P., Balbir-Gurman A., Siegert E., Matucci Cerinic M., Cozzi F., Riemekasten G. et al., 2022/11/28. Rheumatology, 61 (12) pp. 4786-4796. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_3C34847ADF34]
 
Clinical and immunological data from chronic urticaria onset after mRNA SARS-CoV-2 vaccines.
Pescosolido E., Muller Y.D., Sabaté-Brescó M., Ferrer M., Yerly D., Caubet J.C., Lantin J.P., Ribi C., Bergmann M.M., 2022/11. Clinical and experimental allergy, 52 (11) pp. 1343-1346. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_75DE4F933D73]
Inhibiteurs des Janus kinases : nouvelles perspectives pour la médecine de précision ? [Janus kinase inhibitors : new perspectives for precision medicine ?]
Tachet J., Dumusc A., Conrad C., Grandoni F., Chalandon Y., Ribi C., Buclin T., Girardin F., 2022/10/19. Revue medicale suisse, 18 (800) pp. 1979-1983. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_0D12F79D0C49]
Long-term outcomes in corticosteroid-refractory Graves' orbitopathy treated with tocilizumab.
Moi L., Hamedani M., Ribi C., 2022/09. Clinical endocrinology, 97 (3) pp. 363-370. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_EAD5932101A4]
Measurement of circulating CD21-CD27- B lymphocytes in SLE patients is associated with disease activity independently of conventional serological biomarkers.
Horisberger A., Humbel M., Fluder N., Bellanger F., Fenwick C., Ribi C., Comte D., 2022/06/02. Scientific reports, 12 (1) p. 9189. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_79225BAA39D6]
 
Serum interferon-α levels and IFN type I-stimulated genes score perform equally to assess systemic lupus erythematosus disease activity.
Chasset F., Mathian A., Dorgham K., Ribi C., Trendelenburg M., Huynh-Do U., Roux-Lombard P., Courvoisier D.S., Amoura Z., Gorochov G. et al., 2022/06. Annals of the rheumatic diseases, 81 (6) pp. 901-903. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_F017A3490498]
 
Behçet's-like adverse event or inaugural Behçet's disease after SARS-CoV-2 mRNA-1273 vaccination?
Tagini F., Carrel L., Fallet B., Gachoud D., Ribi C., Monti M., 2022/05/05. Rheumatology, 61 (5) pp. e112-e113. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_6E6FC4FFA465]
Humoral Responses Against Variants of Concern by COVID-19 mRNA Vaccines in Immunocompromised Patients.
Obeid M., Suffiotti M., Pellaton C., Bouchaab H., Cairoli A., Salvadé V., Stevenel C., Hottinger R., Pythoud C., Coutechier L. et al., 2022/05/01. JAMA oncology, 8 (5) pp. e220446. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_8956034C5615]
Maladies causées par Anisakis simplex chez l’humain [Human diseases caused by Anisakis simplex]
Ringwald M., Muller Y.D., Ribi C., 2022/04/06. Revue medicale suisse, 18 (776) pp. 634-638.
[URN][DOI][Pmid][serval:BIB_C100DD2F9489]
Réactions d’hypersensibilité au fer intraveineux : le point de vue de l’allergologue [Hypersensitivity reactions to intravenous iron: an allergist' perspective]
Moi L., Stehlin F., Desseauve D., Ribi C., Muller Y.D., 2022/04/06. Revue medicale suisse, 18 (776) pp. 639-645. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_549B88D4BEB5]
Mepolizumab for Eosinophilic Granulomatosis With Polyangiitis: A European Multicenter Observational Study.
Bettiol A., Urban M.L., Dagna L., Cottin V., Franceschini F., Del Giacco S., Schiavon F., Neumann T., Lopalco G., Novikov P. et al., 2022/02. Arthritis & rheumatology, 74 (2) pp. 295-306. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_01372D0A9355]
Allergologie-immunologie - Maladies autoimmunes complexes : quand les glucocorticoïdes ne suffisent plus [Difficult to treat auto-immune diseases : when glucocorticoids are not enough]
Dereme J., Belkoniene M., Ribi C., 2022/01/19. Revue medicale suisse, 18 (764-5) pp. 15-17. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_AECB3687D942]
Sarcoidosis - a multisystem disease.
Franzen D.P., Brutsche M., Nilsson J., Böni C., Daccord C., Distler O., Elsener D., Funke-Chambour M., Gruner C., Hayward-Könnecke H. et al., 2022/01/03. Swiss medical weekly, 152 pp. w30049. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_BE7643C6051D]
Intradermal Testing With COVID-19 mRNA Vaccines Predicts Tolerance.
Stehlin F., Mahdi-Aljedani R., Canton L., Monzambani-Banderet V., Miauton A., Girard C., Kammermann K., Meylan S., Ribi C., Harr T. et al., 2022. Frontiers in allergy, 3 p. 818049. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_308D5854A6E6]
Management of Beta-Lactam Antibiotics Allergy: A Real-Life Study.
Iuliano S., Senn L., Moi L., Muller Y.D., Ribi C., Buss G., Comte D., 2022. Frontiers in allergy, 3 p. 853587. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_6BA45BE8BAD0]
SLAMF Receptor Expression Identifies an Immune Signature That Characterizes Systemic Lupus Erythematosus.
Humbel M., Bellanger F., Horisberger A., Suffiotti M., Fluder N., Makhmutova M., Mathias A., Du Pasquier R., Fenwick C., Ribi C. et al., 2022. Frontiers in immunology, 13 p. 843059. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_439FE028F29F]
Syndrome post-Covid-19 et maladies autoimmunes : un parallèle ?
Ribi Camillo, Seebach Jörg D., 2022. Revue Médicale Suisse, 18 (776) pp. 631-632. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_0B3CC4A933A4]
2021
Approche diagnostique et thérapeutique d’un asthme difficile [Diagnostic and therapeutic approach to difficult asthma]
Grandbastien M., Kolb M., Ribi C., Von Garnier C., 2021/11/17. Revue medicale suisse, 17 (759) pp. 1979-1983. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_F2E0947D9B17]
 
Un sepsis qui laisse sceptique
Cisarovsky Christophe, Gautier Maxime, Ribi Camillo, Kraege Vanessa, Sartori Claudio, 2021/11/09. Forum Médical Suisse ‒ Swiss Medical Forum, 21 (4546) pp. 782-785. Peer-reviewed.
[DOI][serval:BIB_AEC46FCD6E7F]
When obstetrics-gynecology specialists need to call an ophthalmologist urgently: a case report.
Masmejan S., Guex-Crosier Y., Diserens C., Vouga M., Clottu A.S., Ribi C., Mathevet P., Jacot-Guillarmod M., 2021/10/21. Journal of medical case reports, 15 (1) p. 517. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_167F066D1D77]
 
Successful Rapid Oral Desensitization to Ibrutinib in a Patient With Severe Immediate Hypersensitivity Reaction.
Tsilimidos G., Horisberger A., Ribi C., Cairoli A., Stalder G., 2021/10. Clinical lymphoma, myeloma & leukemia, 21 (10) pp. e745-e747. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_ACE484B254A3]
 
Neuro-psychiatric manifestations in patients with systemic lupus erythematosus: A systematic review and results from the Swiss lupus cohort study.
Meier A.L., Bodmer N.S., Wirth C., Bachmann L.M., Ribi C., Pröbstel A.K., Waeber D., Jelcic I., Steiner U.C., Swiss SLE Cohort Study (SSCS), 2021/09. Lupus, 30 (10) pp. 1565-1576. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_28293ADE1035]
 
Variants Affecting the C-Terminal Tail of UNC93B1 Are Not a Common Risk Factor for Systemic Lupus Erythematosus.
Kiener S., Ribi C., Keller I., Chizzolini C., Trendelenburg M., Huynh-Do U., von Kempis J., On Behalf Of Swiss Sle Cohort Study Sscs, Leeb T., 2021/08/19. Genes, 12 (8) p. 1268. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_118F317D2FDE]
The burden of systemic sclerosis in Switzerland - the Swiss systemic sclerosis EUSTAR cohort.
Hernández J., Jordan S., Dobrota R., Iudici M., Hasler P., Ribi C., Villiger P., Vlachoyiannopoulos P., Vacca A., Garzanova L. et al., 2021/07/05. Swiss medical weekly, 151 pp. w20528. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_13A29E01262E]
Donnez-nous aujourd’hui nos chiffres quotidiens !
Seebach J.D., Ribi C., 2021/04/07. Revue medicale suisse, 17 (733) pp. 667-668. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_19DAE61EF00C]
Une allergie insolite : le syndrome cannabis-fruits et legumes [An unusual allergy : cannabis-fruit and vegetable syndrome]
Ringwald M., Moi L., Muller Y.D., Ribi C., 2021/04/07. Revue medicale suisse, 17 (733) pp. 680-683. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_5ED8677C34FC]
 
Vaccins contre le Covid-19 : cibles vaccinales, immunogénicité et réactions allergiques [COVID-19 vaccines: vaccine targets, immunogenicity and allergic reactions]
Fallet B., Miauton A., Comte D., Ribi C., Muller Y.D., 2021/04/07. Revue medicale suisse, 17 (733) pp. 690-696.
[DOI][Pmid][serval:BIB_C0A9B3C05FF4]
Syndrome de Sjögren : du diagnostic au traitement [Sjögren's syndrome: from diagnosis to treatment]
Dumusc A., Ribi C., 2021/03/10. Revue medicale suisse, 17 (729) pp. 477-480. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_9ABBC59CBCE2]
Autoimmune Hemolytic Anemia and Pulmonary Embolism: An Association to Consider.
Solari D., Alberio L., Ribi C., Grandoni F., Stalder G., 2021/01. TH open, 5 (1) pp. e8-e13. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_40479FDB0A11]
 
Epitope-Specific Anti-C1q Autoantibodies in Systemic Lupus Erythematosus.
Kleer J.S., Rabatscher P.A., Weiss J., Leonardi J., Vogt S.B., Kieninger-Gräfitsch A., Chizzolini C., Huynh-Do U., Ribi C., Trendelenburg M., 2021. Frontiers in immunology, 12 p. 761395. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_4A9FA51D0D07]
Restoration of NK Cell Cytotoxic Function With Elotuzumab and Daratumumab Promotes Elimination of Circulating Plasma Cells in Patients With SLE.
Humbel M., Bellanger F., Fluder N., Horisberger A., Suffiotti M., Fenwick C., Ribi C., Comte D., 2021. Frontiers in immunology, 12 p. 645478. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_27C3800011DA]
2020
 
Interprétation du dosage des anticorps anti-phospholipides
Nozic Adnan, Burger Raphael, Alberio Lorenzo, Ribi Camillo, 2020/11/03. Swiss Medical Forum ‒ Schweizerisches Medizin-Forum.
[DOI][serval:BIB_BA768D65F04C]
 
Identification of highly active systemic lupus erythematosus by combined type I interferon and neutrophil gene scores vs classical serologic markers.
Chasset F., Ribi C., Trendelenburg M., Huynh-Do U., Roux-Lombard P., Courvoisier D.S., Chizzolini C., Swiss SLE Cohort Study (SSCS, 2020/11/01. Rheumatology, 59 (11) pp. 3468-3478. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_4A8762699A3C]
 
ANCA-associated life-threatening systemic vasculitis after alemtuzumab treatment for multiple sclerosis.
Horisberger A., Pantazou V., Cuendet G., Ribi C., Dunet V., Théaudin M., 2020/10. Multiple sclerosis, 26 (12) pp. 1599-1602. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_90C58633C44F]
 
ANCA-associated vasculitides: Recommendations of the French Vasculitis Study Group on the use of immunosuppressants and biotherapies for remission induction and maintenance.
Terrier B., Charles P., Aumaître O., Belot A., Bonnotte B., Crabol Y., Durel C.A., Ebbo M., Jourde-Chiche N., Lega J.C. et al., 2020/10. Presse medicale, 49 (3) p. 104031. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_8BECD2241380]
 
Corrigendum to: Predictive factors of severe infections in patients with systemic necrotizing vasculitides: data from 733 patients enrolled in five randomized controlled trials of the French Vasculitis Study Group.
Lafarge A., Joseph A., Pagnoux C., Puéchal X., Cohen P., Samson M., Hamidou M., Karras A., Quemeneur T., Ribi C. et al., 2020/09/01. Rheumatology, 59 (9) p. 2653. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_BF8BF6CB3CF7]
 
Predictive factors of severe infections in patients with systemic necrotizing vasculitides: data from 733 patients enrolled in five randomized controlled trials of the French Vasculitis Study Group.
Lafarge A., Joseph A., Pagnoux C., Puéchal X., Cohen P., Samson M., Hamidou M., Karras A., Quemeneur T., Ribi C. et al., 2020/09/01. Rheumatology, 59 (9) pp. 2250-2257. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_BF7E60D17419]
 
Incidence and risk factors for gangrene in patients with systemic sclerosis from the EUSTAR cohort
Mihai Carina, Distler Oliver, Gheorghiu Ana Maria, Constantin Paul I, Dobrota Rucsandra, Jordan Suzana, Smith Vanessa, Hachulla Eric, Henes Jörg, Siegert Elise et al., 2020/08/01. Rheumatology, 59 (8) pp. 2016-2023.
[DOI][WoS][Pmid][serval:BIB_07BEDE96F20E]
Cardiotoxicité des inhibiteurs de points de contrôle immunitaire utilisés dans le traitement des cancers [Cardiotoxicity of immune checkpoint inhibitors used in cancer treatment]
Arangalage D., Pavon A.G., Hugelshofer S., Desgraz B., Tzimas G., Delyon J., Muller O., Obeid M., Ribi C., Michielin O. et al., 2020/06/03. Revue medicale suisse, 16 (696) pp. 1165-1168. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_A124D4D50BD9]
 
Autoantibody Signature in Cardiac Arrest.
Maguy A., Tardif J.C., Busseuil D., Ribi C., Li J., 2020/06/02. Circulation, 141 (22) pp. 1764-1774. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_57EE7E68DB9A]
Impact of COVID-19 pandemic on SLE: beyond the risk of infection.
Horisberger A., Moi L., Ribi C., Comte D., 2020/05. Lupus science & medicine, 7 (1). Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_2CCD571AE26B]
Maladies autoimmunes dans le contexte de la pandémie COVID-19 [Autoimmune diseases in the context of pandemic COVID-19]
Horisberger A., Moi L., Ribi C., Comte D., 2020/04/29. Revue medicale suisse, 16 (N° 691-2) pp. 827-830. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_23C4ADC982B0]
Angiœdèmes héréditaires sur ­déficit en C1-inhibiteur : nouveautés ­thérapeutiques [Hereditary angioedema due to C1-esterase inhibitor deficiency : novel approaches]
Stehlin F., Ribi C., 2020/04/08. Revue medicale suisse, 16 (689) pp. 675-678. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_5093AD198998]
Prise en charge du syndrome des ­anticorps antiphospholipides chez l’adulte [Management of the antiphospholipid syndrome in adults]
Doms J., Horisberger A., Ribi C., 2020/04/08. Revue medicale suisse, 16 (689) pp. 670-674. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_F55407187560]
 
Anti-apolipoprotein A-1 autoantibodies correlate with disease activity in systemic lupus erythematosus.
Nigolian H., Ribi C., Courvoisier D.S., Pagano S., Alvarez M., Trendelenburg M., Huynh-Do U., Vuilleumier N., Dayer J.M., Chizzolini C. et al., 2020/03/01. Rheumatology, 59 (3) pp. 534-544. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_B6968F86D374]
 
Hémorragie intra-alvéolaire induite par le propylthiouracil
Desmercières Jérémy, Ribi Camillo, Azarnoush Kouchiar, Liaudet Lucas, Matter Maurice, Ribordy et Vincent, 2020/03. La Presse Médicale Formation, 1 (1) pp. 73-76.
[DOI][serval:BIB_4AFFCFFD26E1]
 
Risk of malignancy in patients treated for systemic necrotising vasculitis.
Lafarge A., Joseph A., Pagnoux C., Puechal X., Cohen P., Samson M., Hamidou M., Karras A., Groh M., Quemeneur T. et al., 2020/03. Annals of the rheumatic diseases, 79 (3) pp. 431-433. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_6ABEE6226AA2]
No association of complement mannose-binding lectin deficiency with cardiovascular disease in patients with Systemic Lupus Erythematosus.
Kieninger-Gräfitsch A., Vogt S., Ribi C., Dubler D., Chizzolini C., Huynh-Do U., Osthoff M., Trendelenburg M., 2020/02/28. Scientific reports, 10 (1) p. 3693. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_C2236827B475]
 
Une polyarthrite fébrile récidivante
Konasch Andreas, Lu Henri, Rousakis Markos, Comte Denis, Ribi Camillo, 2020/02/25. Forum Médical Suisse ‒ Swiss Medical Forum.
[DOI][serval:BIB_C86F8FA697A1]
 
Trop de Troponines
Kohli Ribeiro Stphanie, Delabays Alain, Ribi Camillo, Sartori Claudio, 2020/02/11. Forum Médical Suisse ‒ Swiss Medical Forum.
[DOI][serval:BIB_0CB95B589339]
2019
Successful desensitization to pomalidomide in a patient with POEMS syndrome with delayed-type hypersensitivity to immunomodulatory imid drugs.
Grandoni F., Stalder G., Borgeat Kaeser A., Ribi C., Cairoli A., Blum S., 2019/12. Leukemia & lymphoma, 60 (12) pp. 3087-3089. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_A815C7BA260F]
Susceptibility of BAFF-var allele carriers to severe SLE with occurrence of lupus nephritis.
Friebus-Kardash J., Trendelenburg M., Eisenberger U., Ribi C., Chizzolini C., Huynh-Do U., Lang K.S., Wilde B., Kribben A., Witzke O. et al., 2019/11/21. BMC nephrology, 20 (1) p. 430. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_C34DC9FFCE36]
 
Adverse effects of immune-checkpoint inhibitors: epidemiology, management and surveillance.
Martins F., Sofiya L., Sykiotis G.P., Lamine F., Maillard M., Fraga M., Shabafrouz K., Ribi C., Cairoli A., Guex-Crosier Y. et al., 2019/09. Nature reviews. Clinical oncology, 16 (9) pp. 563-580. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_7F8DDEE8DA1E]
Phenotypes Determined by Cluster Analysis and Their Survival in the Prospective European Scleroderma Trials and Research Cohort of Patients With Systemic Sclerosis.
Sobanski V., Giovannelli J., Allanore Y., Riemekasten G., Airò P., Vettori S., Cozzi F., Distler O., Matucci-Cerinic M., Denton C. et al., 2019/09. Arthritis & rheumatology, 71 (9) pp. 1553-1570. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_D5B6E2510518]
Predictors of disease worsening defined by progression of organ damage in diffuse systemic sclerosis: a European Scleroderma Trials and Research (EUSTAR) analysis
Becker Mike, Graf Nicole, Sauter Rafael, Allanore Yannick, Curram John, Denton Christopher P, Khanna Dinesh, Matucci-Cerinic Marco, de Oliveira Pena Janethe, Pope Janet E et al., 2019/09. Annals of the Rheumatic Diseases, 78 (9) pp. 1242-1248.
[URN][DOI][WoS][Pmid][serval:BIB_8A7611119C0A]
 
Outcomes of patients with systemic sclerosis treated with rituximab in contemporary practice: a prospective cohort study
Elhai Muriel, Boubaya Marouane, Distler Oliver, Smith Vanessa, Matucci-Cerinic Marco, Alegre Sancho Juan José, Truchetet Marie-Elise, Braun-Moscovici Yolanda, Iannone Florenzo, Novikov Pavel I et al., 2019/07. Annals of the Rheumatic Diseases, 78 (7) pp. 979-987.
[DOI][WoS][Pmid][serval:BIB_C05206D02249]
 
Association of antibodies against myelin and neuronal antigens with neuroinflammation in systemic lupus erythematosus.
Pröbstel A.K., Thanei M., Erni B., Lecourt A.C., Branco L., André R., Roux-Lombard P., Koenig K.F., Huynh-Do U., Ribi C. et al., 2019/05/01. Rheumatology, 58 (5) pp. 908-913. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_178CB13DB61C]
Progressive skin fibrosis is associated with a decline in lung function and worse survival in patients with diffuse cutaneous systemic sclerosis in the European Scleroderma Trials and Research (EUSTAR) cohort
Wu Wanlong, Jordan Suzana, Graf Nicole, de Oliveira Pena Janethe, Curram John, Allanore Yannick, Matucci-Cerinic Marco, Pope Janet E, Denton Christopher P, Khanna Dinesh et al., 2019/05. Annals of the Rheumatic Diseases, 78 (5) pp. 648-656.
[URN][DOI][WoS][Pmid][serval:BIB_3BA3362D678D]
 
L’allergie au poisson [Allergy to fish]
Mahdi Aljedani R., Ribi C., 2019/04/03. Revue medicale suisse, 15 (645) pp. 706-709. Peer-reviewed.
[Pmid][serval:BIB_ABBDA2836CF0]
The Fatigue Assessment Scale as a simple and reliable tool in systemic lupus erythematosus: a cross-sectional study.
Horisberger A., Courvoisier D., Ribi C., 2019/03/25. Arthritis research & therapy, 21 (1) p. 80. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_581C1DBAA28B]
Treatment of chronic non-infectious uveitis and scleritis.
Rossi D.C., Ribi C., Guex-Crosier Y., 2019/02/25. Swiss medical weekly, 149 pp. w20025. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_CEF6ECB55ECE]
Allergologie-immunologie: Facteurs d’échec du traitement de l’asthme et nouveautés thérapeutiques [Risk of treatment failure and therapeutic novelties in asthma]
Horisberger A., Mahdi Aljedani R., Spertini F., Ribi C., 2019/01/09. Revue medicale suisse, 15 (N° 632-633) pp. 23-26. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_0C52767F8451]
Anti-C1q Antibodies as Occurring in Systemic Lupus Erythematosus Could Be Induced by an Epstein-Barr Virus-Derived Antigenic Site.
Csorba K., Schirmbeck L.A., Tuncer E., Ribi C., Roux-Lombard P., Chizzolini C., Huynh-Do U., Vanhecke D., Trendelenburg M., 2019. Frontiers in immunology, 10 p. 2619. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_6F89C6AE8267]
New therapeutic perspectives to manage refractory immune checkpoint-related toxicities.
Martins F., Sykiotis G.P., Maillard M., Fraga M., Ribi C., Kuntzer T., Michielin O., Peters S., Coukos G., Spertini F. et al., 2019/01. The Lancet. Oncology, 20 (1) pp. e54-e64. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_42DB9145A8A7]
2018
 
Eosinophilic esophagitis: latest insights from diagnosis to therapy.
Schoepfer A., Blanchard C., Dawson H., Lucendo A., Mauro A., Ribi C., Safroneeva E., Savarino E.V., Penagini R., 2018/12. Annals of the New York Academy of Sciences, 1434 (1) pp. 84-93. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_0934BFC8EBCD]
 
Les lymphohistiocytoses hémophagocytaires [Hemophagocytic Lymphohistiocytosis]
Stalder G., Ribi C., Duchosal M.A., 2018/08. Praxis, 107 (16) pp. 902-911. Peer-reviewed.
[DOI][Pmid][serval:BIB_D46E28896440]
 
Prevalence, persistence and clinical correlations of classic and novel antiphospholipid antibodies in systemic lupus erythematosus.
Marchetti T., Ribi C., Perneger T., Trendelenburg M., Huynh-Do U., de Moerloose P., Chizzolini C., 2018/08/01. Rheumatology, 57 (8) pp. 1350-1357. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_37D7EB2120E6]
 
ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (Immune checkpoint inhibitors, cell adhesion inhibitors, sphingosine-1-phosphate receptor modulators and proteasome inhibitors).
Redelman-Sidi G., Michielin O., Cervera C., Ribi C., Aguado J.M., Fernández-Ruiz M., Manuel O., 2018/06. Clinical microbiology and infection, 24 Suppl 2 pp. S95-S107. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_679ECFFACD23]
Churg-Strauss syndrome with cardiac involvement: case illustration and contribution of CMR in the diagnosis and clinical follow-up.
d'Ersu E., Ribi C., Monney P., Vincenti G., Schwitter J., Rotman S., Hullin R., Regamey J., 2018/05/01. International journal of cardiology, 258 pp. 321-324. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_2BC5A8C83FB6]
 
Rhinite allergique saisonnière [Seasonal allergic rhinitis]
Salvadé I., Moi L., Ribi C., Spertini F., 2018/04/04. Revue medicale suisse, 14 (601) pp. 726-730. Peer-reviewed.
[Pmid][serval:BIB_43CB50E772F4]
Antibodies to <i>Chlamydia trachomatis</i> and reproductive health issues in women with SLE: a case-control study.
Santos A., Greub G., Aeby S., Wunder D., Pantaleo G., Ribi C., 2018. Lupus science & medicine, 5 (1) pp. e000293. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_B997988DA92E]
Autoantibodies Against Albumin in Patients With Systemic Lupus Erythematosus.
Nehring J., Schirmbeck L.A., Friebus-Kardash J., Dubler D., Huynh-Do U., Chizzolini C., Ribi C., Trendelenburg M., 2018. Frontiers in immunology, 9 p. 2090. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_35DBB703320E]
 
Immune complexes containing serum B-cell activating factor and immunoglobulin G correlate with disease activity in systemic lupus erythematosus.
Friebus-Kardash J., Branco L., Ribi C., Chizzolini C., Huynh-Do U., Dubler D., Roux-Lombard P., Dolff S., Kribben A., Eisenberger U. et al., 2018/01/01. Nephrology, dialysis, transplantation, 33 (1) pp. 54-64. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_DF84982F47AE]
Serum calcification propensity is independently associated with disease activity in systemic lupus erythematosus.
Dahdal S., Devetzis V., Chalikias G., Tziakas D., Chizzolini C., Ribi C., Trendelenburg M., Eisenberger U., Hauser T., Pasch A. et al., 2018. PloS one, 13 (1) pp. e0188695. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_CDB924CD0726]
2017
 
Differential impact of systemic lupus erythematosus and rheumatoid arthritis on health-related quality of life.
Chaigne B., Finckh A., Alpizar-Rodriguez D., Courvoisier D., Ribi C., Chizzolini C., Swiss Clinical Quality Management Program For Rheumatoid Arthritis, Swiss Systemic Lupus Erythematosus Cohort Study Group, 2017/07. Quality of life research, 26 (7) pp. 1767-1775. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_D395D31B0FE3]
Impact of disease activity on health-related quality of life in systemic lupus erythematosus - a cross-sectional analysis of the Swiss Systemic Lupus Erythematosus Cohort Study (SSCS).
Chaigne B., Chizzolini C., Perneger T., Trendelenburg M., Huynh-Do U., Dayer E., Stoll T., von Kempis J., Ribi C., Swiss Systemic Lupus Erythematosus Cohort Study Group, 2017/04/28. BMC immunology, 18 (1) p. 17. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_BF3D03BABBDB]
 
Allergie au liquide séminal [Allergy to human seminal plasma]
Moi L., Salvadé I., Ribi C., 2017/04/05. Revue medicale suisse, 13 (557) pp. 748-753. Peer-reviewed.
[Pmid][serval:BIB_50BD1E79A5CE]
 
Etat fébrile avec neutrophilie, éruption cutanée et perturbation des tests hépatiques
Fischer Jessica Valeria, Maitre Sylvie, Lamy Olivier, Ribi Camillo, 2017/03/14. Forum Médical Suisse ‒ Swiss Medical Forum, 17 (11).
[DOI][serval:BIB_74C415653F65]
 
Allergologie-immunologie Clinique. Sensibilité au blé non cœliaque – la fin d’un mythe ? [Non-celiac wheat sensitivity - growing evidence for a wheat-dependent immune-mediated disease]
Ribi C., 2017/01/11. Revue medicale suisse, 13 (544-545) pp. 16-17. Peer-reviewed.
[Pmid][serval:BIB_C76CAE91362D]
 
Infections Associated with Immunobiologics
Delaloye Julie, Conrad Curdin, Gilliet Michel, Pantaleo Giuseppe, Ribi Camillo, 2017. pp. 796-804.e2 dans Infectious Diseases, Elsevier.
[DOI][serval:BIB_06C1D35B4310]
 
Le syndrome de Widal en pratique clinique []
Borgeat Kaeser A., Ribi C., 2017. Praxis, 106 (22) pp. 1243-1249. Peer-reviewed.
[DOI][Pmid][serval:BIB_1320A169B273]
2016
Prediction of improvement in skin fibrosis in diffuse cutaneous systemic sclerosis: a EUSTAR analysis
Dobrota Rucsandra, Maurer Britta, Graf Nicole, Jordan Suzana, Mihai Carina, Kowal-Bielecka Otylia, Allanore Yannick, Distler Oliver, 2016/10. Annals of the Rheumatic Diseases, 75 (10) pp. 1743-1748.
[URN][DOI][WoS][Pmid][serval:BIB_9EB7FA9C3597]
 
Quand un diagnostic peut cacher un autre
Anastasiou Maria, Lamy Oliver, Ribi Camillo, Zufferey Pascal, Gianinazzi Francesco, Benmachiche Malik, 2016/09/06. Forum Médical Suisse ‒ Swiss Medical Forum, 16 (36).
[DOI][serval:BIB_A27FB94F681A]
 
Gastroentérite à éosinophiles [Eosinophilic gastrointestinal disorders]
Burgmann K., Brunel C., Sempoux C., Ribi C., Godat S., Moradpour D., Schoepfer A.M., 2016/08/31. Revue medicale suisse, 13 (528) pp. 1430-1433. Peer-reviewed.
[Pmid][serval:BIB_6D936DDE9696]
 
"Qui s'y frotte s'y pique": réactions urticariennes aux insectes de nos regions [If you go looking for trouble you'll find it. Urticarial reactions to insects of our local areas]
Maitre S., Kaeser A., Di Lucca J., Spertini F., Ribi C., 2016/04/06. Revue medicale suisse, 12 (513) pp. 691-697. Peer-reviewed.
[Pmid][serval:BIB_6937F63A1071]
 
Syndrome de Sjögren: quand le suspecter et comment le confirmer? [Sjögren's syndrome: when to suspect and how to confirm?]
Liapi A., Horisberger A., François S., Ribi C., 2016/04/06. Revue medicale suisse, 12 (513) pp. 698-702. Peer-reviewed.
[Pmid][serval:BIB_2DE66B2BCA26]
 
Low pre-treatment B-cell counts are not a risk factor of infection in patients treated with rituximab for autoimmune diseases: An observational study
Lazarou Ilias, Finckh Axel, Fischer Lara, Ribi Camillo, Gascon Danielle, Seebach Jörg D., Guerne Pierre-André, 2016/03. Joint Bone Spine, 83 (2) pp. 191-197.
[DOI][WoS][Pmid][serval:BIB_3C9D59DD6904]
2015
 
Artérite de Horton: recommandations Lausannoises de prise en charge [Giant cell arteritis: guidelines of the University Hospital of Lausanne].
Tsetsou S., Michel P., Ribi C., Hirt L., Kawasaki A., Hugli O., De Leval L., Bart P.A., Waeber G., Meuli R. et al., 2015/02. Revue Médicale Suisse, 11 (461) pp. 411-417.
[Pmid][serval:BIB_14E431815FB6]
 
Allergologie--immunologie clinique. (3.) Nouveaux auto-anticorps dans les myopathies infammatoires et la sclérose systémique [Novel autoantibodies in inflammatory myopathies and systemic sclerosis]
Ribi C., 2015/01/14. Revue medicale suisse, 11 (456-457) pp. 25-29. Peer-reviewed.
[Pmid][serval:BIB_8EC7EA568AA5]
 
Maladie de Whipple: quand y penser [Whipple's disease, when to think about it?].
Cunningham S., Maulucci F., Zufferey P., Ribi C., Maillard M.H., 2015. Revue Médicale Suisse, 11 (484) pp. 1582, 1584-1582, 1586.
[Pmid][serval:BIB_A63A4F86862D]
Pneumococcal polysaccharide vaccination in adults undergoing immunosuppressive treatment for inflammatory diseases - a longitudinal study.
Fischer L., Gerstel P.F., Poncet A., Siegrist C.A., Laffitte E., Gabay C., Seebach J.D., Ribi C., 2015. Arthritis Research and Therapy, 17 p. 151. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_935C40DB3F76]
 
Prevalence of vascular disease in systemic lupus erythematosus compared with type-1 diabetes mellitus: A cross-sectional study of two cohorts.
Koenig K.F., Ribi C., Radosavac M., Zulewski H., Trendelenburg M., Swiss SLE cohort study (SSCS), 2015. Lupus, 24 (1) pp. 58-65. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_8A0D788B2ACA]
 
Syndromes myélodysplasiques et auto-immunité [Myelodysplastic syndromes and autoimmunity].
Stalder G., Alberio L., Ribi C., 2015. Revue Médicale Suisse, 11 (469) pp. 820-2, 824-5.
[Pmid][serval:BIB_2652D42C3E88]
Vaccination recommendations for adult patients with autoimmune inflammatory rheumatic diseases
Bühler S., Eperon G., Ribi C., Kyburz D., van Gompel F., Visser L.G., Siegrist C.A., Hatz C., 2015. Swiss Medical Weekly, 145 pp. w14159. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_D3C53DF1586B]
2014
 
Mononeuritis multiplex predicts the need for immunosuppressive or immunomodulatory drugs for EGPA, PAN and MPA patients without poor-prognosis factors.
Samson M., Puéchal X., Devilliers H., Ribi C., Cohen P., Bienvenu B., Terrier B., Pagnoux C., Mouthon L., Guillevin L. et al., 2014/09. Autoimmunity reviews, 13 (9) pp. 945-953. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_C14F9BAB68A8]
 
Anaphylaxie aux colorants bleus [Anaphylaxis to blue dyes]
Langner-Viviani F., Chappuis S., Bergmann M.M., Ribi C., 2014/04/16. Revue medicale suisse, 10 (426) pp. 876-880. Peer-reviewed.
[Pmid][serval:BIB_5D23836C01B0]
 
Allergie ou intolérance alimentaire [Food allergy or food intolerance?].
Maître S., Maniu C.M., Buss G., Maillard M.H., Spertini F., Ribi C., 2014. Revue Médicale Suisse, 10 (426) pp. 846-50, 852-3.
[Pmid][serval:BIB_4716A2B9CE96]
 
Long-term follow-up of a randomized trial on 118 patients with polyarteritis nodosa or microscopic polyangiitis without poor-prognosis factors.
Samson M., Puéchal X., Devilliers H., Ribi C., Cohen P., Bienvenu B., Ruivard M., Terrier B., Pagnoux C., Mouthon L. et al., 2014. Autoimmunity Reviews, 13 (2) pp. 197-205.
[DOI][WoS][Pmid][serval:BIB_136EE4DA51CA]
The Swiss Systemic lupus erythematosus Cohort Study (SSCS) - cross-sectional analysis of clinical characteristics and treatments across different medical disciplines in Switzerland.
Ribi C., Trendelenburg M., Gayet-Ageron A., Cohen C., Dayer E., Eisenberger U., Hauser T., Hunziker T., Leimgruber A., Lindner G. et al., 2014. Swiss Medical Weekly, 144 pp. w13990. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_2974FF159755]
 
Un cas inhabituel d'allergie au champagne [A case of unusual allergy to champagne].
Carron P.N., Vionnet J., Ribi C., Pasquier M., Hugli O., 2014. Presse Médicale, 43 (10 Pt 1) pp. 1127-1129. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_824EE412E742]
2013
 
Systemischer Lupus Erythematodes – die «Swiss SLE Cohort Study (SSCS)»
Trendelenburg Marten, Ribi Camillo, 2013/05/29. Forum Médical Suisse ‒ Swiss Medical Forum, 13 (22).
[DOI][serval:BIB_71B58D0F776F]
 
Eosinophilic granulomatosis with polyangiitis (Churg–Strauss) (EGPA), polyarteritis nodosa (PAN) and microscopic polyangiitis (MPA) with no initial Five-Factor Score-defined poor-prognosis factors (FFS=0): Baseline factors associated with cytotoxic agent and immunomodulator prescription
Samson M., Puéchal X., Devilliers H., Ribi C., Cohen P., Bienvenu B., Pagnoux C., Mouthon L., Guillevin L., 2013/04. La Presse Médicale, 42 (4) p. 666.
[DOI][WoS][serval:BIB_8CE4ADCD3172]
 
Eosinophilie sanguine: quel bilan, quel cheminement diagnostique [Peripheral blood eosinophilia: diagnostic value and further assessment].
Chappuis S., Ribi C., Greub G., Spertini F., 2013. Revue Médicale Suisse, 9 (382) pp. 819-825.
[Pmid][serval:BIB_07BFF61EE37B]
 
Formes sévères d'hypersensibilité médicamenteuse retardée [Severe delayed drug hypersensitivity reactions].
Maniu C.M., Buss G., Feldmeyer L., Spertini F., Ribi C., 2013. Revue Médicale Suisse, 9 (382) pp. 803-811.
[Pmid][serval:BIB_B7B36335E226]
 
Immunosuppresseurs: usages systémiques et neurologiques [Systemic and neurological uses of immunosuppressive agents].
Schnider C., Seebach J.D., Ribi C., Spertini F., 2013. Revue Médicale Suisse, 9 (384) pp. 915-921.
[Pmid][serval:BIB_6274D4C3C9C3]
 
Long-term outcomes of 118 patients with eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome) enrolled in two prospective trials.
Samson M., Puéchal X., Devilliers H., Ribi C., Cohen P., Stern M., Pagnoux C., Mouthon L., Guillevin L., French Vasculitis Study Group, 2013. Journal of Autoimmunity, 43 pp. 60-69.
[DOI][WoS][Pmid][serval:BIB_C9E76490EEB2]
2012
 
Protective Antibody Responses to Influenza A/H1N1/09 Vaccination in Children With Celiac Disease
Schäppi Michela G., Meier Sara, Bel Michael, Siegrist Claire-Anne, Posfay-Barbe Klara M., 2012/06. Journal of Pediatric Gastroenterology & Nutrition, 54 (6) pp. 817-819.
[DOI][WoS][Pmid][serval:BIB_EBD227857C11]
 
Atteintes neurologiques centrales du lupus érythémateux systémique [Central neuropsychiatric involvement in systemic lupus erythematosus]
Madrane S., Ribi C., 2012/04/18. Revue medicale suisse, 8 (337) pp. 848-853. Peer-reviewed.
[Pmid][serval:BIB_A493E07D5057]
 
Hypersensibilité aux inhibiteurs de la pompe à protons [Hypersensitivity to proton pump inhibitors]
Bergmann M., Guignard B., Ribi C., 2012/04/18. Revue medicale suisse, 8 (337) pp. 830-835. Peer-reviewed.
[Pmid][serval:BIB_EA409BD9FCD1]
 
Strong serological responses and HIV RNA increase following AS03-adjuvanted pandemic immunization in HIV-infected patients : AS03-adjuvanted influenza vaccine in HIV
Calmy A, Bel M, Nguyen A, Combescure C, Delhumeau C, Meier S, Yerly S, Kaiser L, Hirschel B, Siegrist C-A, 2012/04. HIV Medicine, 13 (4) pp. 207-218.
[DOI][WoS][Pmid][serval:BIB_FB5D60417D81]
Higher memory responses in HIV-infected and kidney transplanted patients than in healthy subjects following priming with the pandemic vaccine.
Siegrist C.A., van Delden C., Bel M., Combescure C., Delhumeau C., Cavassini M., Clerc O., Meier S., Hadaya K., Soccal P.M. et al., 2012. Plos One, 7 (7) pp. e40428. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_2314A746CDE2]
 
Responses of solid organ transplant recipients to the AS03-adjuvanted pandemic influenza vaccine
Siegrist Claire-Anne, Ambrosioni Juan, Bel Michael, Combescure Christophe, Hadaya Karine, Martin Pierre-Yves, Soccal Paola M, Berney Thierry, Noble Stephane, Meier Sara et al., 2012. Antiviral Therapy, 17 (5) pp. 893-903.
[DOI][WoS][Pmid][serval:BIB_4A7101D213C1]
2011
 
Hypereosinophilia in patients with multiple sclerosis treated with natalizumab
Abbas M., Lalive P. H., Chofflon M., Simon H.- U., Chizzolini C., Ribi C., 2011/10/18. Neurology, 77 (16) pp. 1561-1564.
[DOI][WoS][Pmid][serval:BIB_35A444DF88A2]
 
Graft-versus-host disease is the major determinant of humoral responses to the AS03-adjuvanted influenza A/09/H1N1 vaccine in allogeneic hematopoietic stem cell transplant recipients
Mohty B., Bel M., Vukicevic M., Nagy M., Levrat E., Meier S., Grillet S., Combescure C., Kaiser L., Chalandon Y. et al., 2011/06/01. Haematologica, 96 (6) pp. 896-904.
[DOI][WoS][Pmid][serval:BIB_7EF4AD809309]
 
Impact of synthetic and biologic disease-modifying antirheumatic drugs on antibody responses to the AS03-adjuvanted pandemic influenza vaccine: a prospective, open-label, parallel-cohort, single-center study.
Gabay C., Bel M., Combescure C., Ribi C., Meier S., Posfay-Barbe K., Grillet S., Seebach J.D., Kaiser L., Wunderli W. et al., 2011/06. Arthritis and rheumatism, 63 (6) pp. 1486-1496. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_EBC326DF75C4]
2010
 
Réactions d'hypersensibilité immédiates aux anti-inflammatoires non stéroïdiens: allergie ou pseudo-allergie? [Immediate hypersenstivity reactions to nonsteroidal anti-inflammatory drugs: allergy or pseudo-allergy?]
Brandstätter H., Samer C.F., Ribi C., Piguet V., 2010/06/30. Revue medicale suisse, 6 (255) pp. 1345-1348, 1350. Peer-reviewed.
[Pmid][serval:BIB_DF7EFB2EE182]
 
La polychondrite chronique atrophiante [Relapsing polychondritis]
Arlettaz L., Ribi C., 2010/04/21. Revue medicale suisse, 6 (245) pp. 830-834. Peer-reviewed.
[Pmid][serval:BIB_7472B76077EF]
 
Treatment of polyarteritis nodosa and microscopic polyangiitis without poor-prognosis factors: A prospective randomized study of one hundred twenty-four patients.
Ribi C., Cohen P., Pagnoux C., Mahr A., Arène J.P., Puéchal X., Carli P., Kyndt X., Le Hello C., Letellier P. et al., 2010/04. Arthritis and rheumatism, 62 (4) pp. 1186-1197. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_1394D1307D63]
2009
 
Création d'une cohorte suisse de patients lupiques: the Swiss systemic lupus erythematosus cohort study (SSCS) [Towards the Swiss systemic lupus erythematosus cohort study (SSCS)]
Chizzolini C., Cohen C.D., Eisenberger U., Hauser T., Hunziker T., Leimgruber A., Pechula M., Ribi C., Stoll T., Trendelenburg M. et al., 2009/04/15. Revue medicale suisse, 5 (199) pp. 808-811. Peer-reviewed.
[Pmid][serval:BIB_66DA2849C864]
2008
 
Localized cold-induced urticaria associated with specific immunotherapy for tree pollen allergy.
Ducommun J., Morel V., Ribi C., Hauser C., 2008/06. Allergy, 63 (6) pp. 789-790. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_BFB5498904A8]
 
Maladie de Still de l'adulte [Adult onset Still's disease]
Ribi C., 2008/04/23. Revue medicale suisse, 4 (154) pp. 1039-1044. Peer-reviewed.
[Pmid][serval:BIB_EB0A51824BDD]
 
Treatment of Churg-Strauss syndrome without poor-prognosis factors: a multicenter, prospective, randomized, open-label study of seventy-two patients.
Ribi C., Cohen P., Pagnoux C., Mahr A., Arène J.P., Lauque D., Puéchal X., Letellier P., Delaval P., Cordier J.F. et al., 2008/02. Arthritis and rheumatism, 58 (2) pp. 586-594. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_0E0A87F98A41]
2006
 
Combined antiviral-immunosuppressive treatment in human T-lymphotrophic virus 1-Sjögren-associated myelopathy.
Pot C., Chizzolini C., Vokatch N., Tiercy J.M., Ribi C., Landis T., Perren F., 2006/09. Archives of neurology, 63 (9) pp. 1318-1320. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_54BD6954B2D5]
2005
 
Efficacy of TNF {alpha} blockade in cyclophosphamide resistant neuro-Behçet disease.
Ribi C., Sztajzel R., Delavelle J., Chizzolini C., 2005/12. Journal of neurology, neurosurgery, and psychiatry, 76 (12) pp. 1733-1735. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_8BDEC3D75429]
 
Pseudovasculitis and corticosteroid therapy.
Ribi C., Mauget D., Egger J.F., Khatchatourian G., Villard J., 2005/09. Clinical rheumatology, 24 (5) pp. 539-543. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_D4EDE5408299]
2003
 
Anaphylactic reactions to tolperisone (Mydocalm).
Ribi C., Vermeulen C., Hauser C., 2003/06/28. Swiss medical weekly, 133 (25-26) pp. 369-371. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_8312E8EE3798]
2002
 
Adverse reactions to pyrazinamide.
Ribi C., Hauser C., 2002/10. Allergy, 57 (10) pp. 964-965. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_699CA4ABD4C0]
Partagez:
Unicentre - CH-1015 Lausanne
Suisse
Tél. +41 21 692 11 11
Canton de Vaud
Swiss University